Worm.com

Electron Micrographs Confirm Virus Destruction

WEST HAVEN, Conn. — In startling new imagery, a drug developed by NanoViricides, Inc. (Pink Sheets: NNVC) dismantles a virus particle in a visual demonstration of the novel mechanism of action of nanoviricides in vitro.

NanoViricides’ President Dr. Anil Diwan unveiled the electron micrographs at the Nano Science and Technology Institute’s (NSTI) Nanotech2007 Conference in Santa Clara, CA, May 24. An abstract of the presentation can be viewed at BioNano: NanoMedicine, Diagnostics, Imaging & Therapies (http://www.nsti.org/Nanotech2007/showabstract.html?absno=281).

The electron micrograph can be seen on the company’s website at NanoViricides Dismantling MCMV as seen in TEM (http://www.nanoviricides.com/nnvc-tem.pdf).

Different broad-spectrum nanoviricides were shown to dismantle the envelope coat of the murine cytomegalovirus, (mCMV) releasing the virus capsids it contains. The released capsids, which contain the genome of the virus particle, are no longer infectious. "This is the first visual demonstration that nanoviricides attack viruses in vitro just the way we’ve designed them to do so," said Dr. Diwan.

The murine CMV is closely related to the human CMV, which causes various diseases, including ocular diseases such as retinopathy and blindness, especially in immunocompromised patients such as HIV/AIDS cases. CMV has become a major management problem in persons living with AIDS and represents a therapeutic challenge to physicians caring for this population.

Dr. Diwan also presented survival data in mice infected with an otherwise lethal dose of rabies. "That the nanoviricides treatments enabled the animals to survive at all is a major breakthrough in rabies," he noted.

"We now know that our broad spectrum drug candidates are capable of attacking H5N1 bird flu viruses of both Clade 1 and Clade 2 varieties, common influenzas, rabies, and also cytomegalovirus," said NanoViricides’ CEO Eugene Seymour, MD, MPH.

"Just as ampicillin works against a wide range of bacteria, we believe broad-spectrum nanoviricides can be designed to work against a wide range of viruses," he added further.

There can be no assurance that this demonstration or the results of our animal studies may ever lead to the development of a nanopharmaceutical product approved for commercial resale or that, if approved, a commercial market will develop for our products.

About NanoViricides: http://www.nanoviricides.com

NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the company to be different from those expressed or implied including the success of the Company’s research and development strategy, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process, described in the "Management’s Discussion and Analysis" section of the Company’s Form 10-KSB and other reports and filings with the Securities and Exchange Commission.

COPYRIGHT 2007 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

Information provided by: Findarticles.com

HONG KONG (AFP) — Hong Kong health officials were Wednesday testing a starling found dead with suspected bird flu.

Authorities said preliminary tests indicated the bird, found in the densely populated Mong Kok district, was infected with H5 flu, but they could not yet say whether it was the killer H5N1 strain. Further tests are being conducted.

More than a dozen wild birds have been found dead in Hong Kong with the H5N1 virus, which has killed almost 200 people and ravaged poultry flocks worldwide since 2003.

Migratory birds have …

Information provided by: Findarticles.com

Kaspersky
Lab , a leading developer of Internet threat management solutions that
protect against viruses, spyware, hackers and spam, today announced that Kaspersky
Anti-Virus 6.0 has been honored with accolades from both PC World
magazine and Virus Bulletin for its outstanding performance.

PC World is the most widely read computer and business publication. Virus
Bulletin is an authoritative international publication on computer malware
and spam.

Kaspersky Anti-Virus 6.0 (KAV) is the Company’s core
personal anti-virus product that has set new standards for protecting
individual computer users against viruses, Trojans, worms, spyware and
rootkits. KAV -

--  Is consistently ranked by independent testing labs as the top rated
    premium solution for detecting viruses and spyware  (AV-Comparatives.org);
--  Offers the fastest outbreak response time of all anti-malware
    solutions according to independent studies (AV-Test.org*);
--  Continues to push out more anti-malware updates per month than any
    other competitive solution and offers standard automated hourly anti-
    malware updates against the latest threats; and
--  Requires the lowest system resources of any anti-malware software
    (CNET).
    

PC World’s review considered eight leading
stand-alone anti-virus applications and their virus and spyware
capabilities as related to Vista.

*Testing was done in partnership with AV-Test.org.

PC World Quotes:

“Kaspersky Anti-Virus 6.0, shines for its top-notch malware detection and
disinfection rates. It boasts a 96 percent detection rate, and cleaned 86
percent of all items in our disinfection tests.” — June 2007 issue

“It is also the fastest at delivering new signatures out of the eight
tested programs, with an average response time of 0 to 2 hours.” — June
2007 issue

“PC security is as important as ever, and Kaspersky’s fast response to
outbreaks makes this a first-rate tool for locking down your PC.” — July
2007 issue

Virus Bulletin published a
comparative review of Windows Vista-compatible anti-virus solutions for
home users. In addition to malicious program detection rates, the test
examined the effect of various anti-virus products on overall system
performance. The Beta version of Kaspersky Anti-Virus 6.0 was awarded a
VB100 for its detection of threats in the wild and also scored the best
rating when measuring how much a system was slowed by the scanning of
files, archives and documents when the products were configured with
default settings.

“These prestigious awards are tangible recognition of Kaspersky’s ongoing
commitment to providing our customers with the highest-quality of
protection against viruses and other forms of malware,” said Randy Drawas,
vice president of marketing, Kaspersky Lab, Inc. “We are very pleased that
Kaspersky Anti-Virus 6.0 has twice been singled out as the top antivirus
product by these two well-respected publications.”

Kaspersky was also recently recognized by SC Magazine for its enterprise
solution, Kaspersky Open Space Security. Kaspersky won “highly commended” in three
categories of the prestigious awards: Best Anti-Malware Solution; Best SME
Security Solution; and Security Product of the Year. It was also a
finalist in four categories of the awards: Best Anti-Malware Solution; Best
SME Security Solution; Security Product of the Year; and the Innovation
Award for Technology. The SC Magazine awards showcase the best products
and services in the information security industry, and are voted for by
both readers of the international IT security magazine and an independent
judging panel.

About Kaspersky Lab

Kaspersky Lab delivers the world’s most immediate protection against IT
security threats, including viruses, spyware, crimeware, hackers, phishing
and spam. Kaspersky Lab products provide superior detection rates and the
industry’s fastest outbreak response time for large enterprises, SMBs, home
users and the mobile computing environment. Kaspersky® technology is
also used worldwide inside the products and services of more than 100 of
the industry’s leading IT security solution providers. Learn more at
www.kaspersky.com . For the latest on antivirus, anti-spyware, anti-spam
and other IT security issues and trends, visit www.viruslist.com .

Image Available: http://www.marketwire.com/mw/frame_mw?attachid=499780
Image Available: http://www.marketwire.com/mw/frame_mw?attachid=499781
Image Available: http://www.marketwire.com/mw/frame_mw?attachid=499778

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact Information
Randy Drawas
Kaspersky Lab, Inc.
+ 1 781 503 1802
randy.drawas@kaspersky.com

Jennifer Jewett
SHIFT Communications
+ 1 617 779 1852
jjewett@shiftcomm.com

Information provided by: Findarticles.com

"There was no public testimony–why we were jumping so fast into a vaccine that was not for a true communicable disease."

State Senator Glenn Hegar sponsored the bill that overturned Governor Rick Perry’s order. In the Senate, the measure passed 30 to 1.

COPYRIGHT 2007 American Opinion Publishing, Inc.
COPYRIGHT 2008 Gale, Cengage Learning

Information provided by: Findarticles.com

GENEVA (AFP) — The World Health Organisation on Wednesday adopted an interim deal on bird flu virus sample sharing, temporarily resolving a dispute that was threatening efforts to prevent a global pandemic, a senior official said.

The 193 member states in the agency’s assembly approved a resolution on sharing viruses and access to flu vaccines without a vote.

“Countries have agreed to share viruses until another mechanism is set up,” WHO transmissible diseases chief David Heymann said.

“This is a very important commitment by the 193 countries,” he told journalists.

Indonesia — the country most affected by H5N1 bird flu this year — had stopped sending viruses to foreign laboratories until recently and demanded changes to the global flu surveillance system to ensure developing countries get a fair deal.

Sample sharing allows confirmation of suspected human cases of bird flu by one of eight WHO reference laboratories around the world. The …

Information provided by: Findarticles.com

To: FOREIGN EDITORS

Contact: HHS Press Office, +1-202-690-6343

WASHINGTON, May 23 /PRNewswire-USNewswire/ — The following
statement was released today by the U.S. Department of Health and
Human Services:

I am pleased the World Health Assembly has adopted a resolution on
pandemic influenza preparedness that makes clear that Member States
must continue to share influenza specimens and viruses with the World
Health Organization’s (WHO) Global Influenza Surveillance Network.

I am also pleased that the resolution emphasizes the need for
increased vaccine access. We have invested heavily in the …

Read the rest of this article with a Free Trial at HighBeam Research.

Information provided by: Findarticles.com

COPENHAGEN, Denmark, May 21 /PRNewswire/ — Genmab A/S (CSE: GEN) announced today its fully human antibody HuMax-HepC(TM) prevented Hepatitis C virus (HCV) infection in a novel animal model. In the pre-clinical study, mice with a compromised immune system were transplanted with human liver cells (hepatocytes) and exposed to a mixture of patient-derived HCV of different genotypes

Replication of HCV was not observed in 5 of 6 mice (83%) treated with HuMax-HepC, indicating that HuMax-HepC completely prevented HCV infection. The sixth mouse was infected with HCV, but the virus was …

Read the rest of this article with a Free Trial at HighBeam Research.

Information provided by: Findarticles.com

CORPORATE IT UPDATE-(C)1995-2007 M2 COMMUNICATIONS LTD

Kaspersky Lab, a developer of secure content management solutions, has confirmed that its Anti-Virus for Microsoft ISA Server version 5.6 is now compatible with Microsoft ISA Server 2006 Enterprise Edition.

Kaspersky Lab said the application offers centralised management of protection parameters for all servers operating as server array members and also enables centralised updating of anti-virus databases.

According to Kaspersky Lab, Anti-Virus for Microsoft ISA Server provides anti-virus protection for all files transferred using the HTTP and FTP protocols, via Microsoft Internet Security and Acceleration Server. It said the application serves as a filter, intercepting packets transferred via HTTP and FTP protocols, isolating controlled objects from the data and analysing them for viruses.

Kaspersky Anti-Virus for Microsoft ISA Server includes features such as monitoring of system operation statistics and diagnostics and flexible configuration of virus scanning parameters. It is managed via an interface designed for the Microsoft Management Console, which ensures full control over the operation for system administrators and allows them to reduce server load with lists of trusted servers and excluded object types.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2007 M2 Communications Ltd.
COPYRIGHT 2008 Gale, Cengage Learning

Information provided by: Findarticles.com

ITHACA, New York (ENS) —
–>

A lethal fish virus in the Great Lakes and neighboring waterways is approaching epidemic proportions, says Paul Bowser, Cornell professor of aquatic animal medicine in the College of Veterinary Medicine.

The viral hemorrhagic septicemia virus, VHSV, which causes anemia and hemorrhaging in fish, has now been identified in 19 species and poses a potential threat to New York’s $1.2 billion sport-fishing industry.

This month the Wisconsin Department of Natural Resources made a presumptive identification of the virus for the first time in the Lake Winnebago chain of inland lakes about 25 miles south of Green Bay on Lake Michigan - confirmation is pending.

“It’s pretty obvious this is an epidemic even if it isn’t official,” said Bowser. “There are just so many species affected and so many mortalities.”

Three new fish kills have occurred in 2007 in New York waters since …

Information provided by: Findarticles.com